Abstract
INTRODUCTION
This report uses 2023-2024 National Vital Statistic System data to present the demographic group and by the type of drugs involved, specifically opioids and stimulants, with a focus on changes from 2023 to 2024.
METHODS
Data from the 2023-2024 NVSS were used for this analysis. Estimates are based on the National Vital Statistics System multiple-cause-of-death mortality files (1). Drug poisoning (overdose) deaths were defined as having an International Classification of Diseases, 10th Revision underlying cause-of-death code of X40-X44 (unintentional), X60-X64 (suicide), X85 (homicide), or Y10-Y14 (undetermined intent). Population estimates for 2023-2024 were estimated as of July 1, based on the blended base produced by the U.S. Census Bureau instead of the April 1, 2020, decennial population count. All of the race categories are single race, meaning that only one race was reported on the death certificate.
KEY FINDINGS
The age-adjusted drug overdose death rate decreased between 2022 and 2024, with the largest decrease, 26.2%, occurring from 2023 to 2024, from 31.3 deaths per 100,000 standard population to 23.1. From 2023 to 2024, rates of drug overdose deaths declined for all age groups, with the largest decrease occurring for younger age groups. From 2023 to 2024, rates declined for each race and Hispanic-origin group, with the largest decreases occurring for Black non-Hispanic people. Between 2023 and 2024, the drug overdose death rate involving synthetic opioids other than methadone decreased by 35.6% (from 22.2 to 14.3). Between 2023 and 2024, the rates of drug overdose deaths involving psychostimulants with abuse potential and cocaine both declined.
Full text of this article can be found in Bookshelf.
References
- National Center for Health Statistics. Mortality multiple cause files. 2024.
- Garnett MF, Miniño AM. Drug overdose deaths in the United States, 2003–2023. NCHS Data Brief. 2024 Dec;(522):1–12. DOI: https://dx.doi.org/10.15620/cdc/170565. 10.15620/cdc/170565PMC12278041 [DOI] [PubMed]
- The White House. Overdose Prevention Week, 2025. 2025 Aug. Available from: https://www.whitehouse.gov/presidential-actions/2025/08/overdose-prevention-week-2025/.
- U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Healthy People 2030. Reduce drug overdose deaths—SU-03. Healthy People 2030. 2025. Available from: https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/drug-and-alcohol-use/reduce-drug-overdose-deaths-su-03.
- Kochanek KD, Murphy SL, Xu JQ, Arias E. Deaths: Final data for 2020. Natl Vital Stat Rep. 2023 Sep 22;72(10):1–92. DOI: https://dx.doi.org/10.15620/cdc:131355. doi: 10.15620/cdc:131355. [DOI] [PubMed]
- Office of Management and Budget. Revisions to the standards for the classification of federal data on race and ethnicity. Fed Regist. 1997 Oct 30;62(210):58782–90.
- Arias E, Heron M, Hakes JK. The validity of race and Hispanic-origin reporting on death certificates in the United States: An update. National Center for Health Statistics. Vital Health Stat 2 2016;(172)1–29. [PubMed]
- Arias E, Xu JQ, Curtin S, Bastian B, Tejada-Vera B. Mortality profile of the non-Hispanic American Indian or Alaska Native population, 2019. Natl Vital Stat Rep. 2021 Nov 9;70(12):1–27. DOI: https://dx.doi.org/10.15620/cdc:110370. doi: 10.15620/cdc:110370. [DOI] [PubMed]
- National Cancer Institute. Joinpoint Regression Program (Version 5.0.2) [computer software]. 2023.
- Ingram DD, Malec DJ, Makuc DM, Kruszon-Moran D, Gindi RM, Albert M, et al. National Center for Health Statistics guidelines for analysis of trends. National Center for Health Statistics. Vital Health Stat 2 2018;(179)1–71. [PubMed]
